FDA cargo thief warning
This article was originally published in The Tan Sheet
Executive Summary
In an April 28 letter, FDA directs manufacturers, wholesalers and retailers to "immediately review their in-transit and warehouse security practices" to prevent cargo theft - an increasing industry problem (1"The Tan Sheet" March 1, 2010). Firms should proactively plan a response to a theft "since swift action is essential" to protect the public, the agency said. It explained stolen products can cause adverse events if stored or handled improperly. If products are stolen, firms should promptly notify FDA's Office of Criminal Investigations and the public. In some cases firms will need to recall products with the same lot numbers as the stolen products, FDA said. The agency typically will ask the firm for details about the stolen product, a risk assessment and an action plan
You may also be interested in...
In Brief
GSK victim of OTC cargo theft
GSK consumer products stolen
Multiple cases of GlaxoSmithKline OTC products and Rx drugs were stolen Jan. 29 while being transported from a distributor to wholesalers in the Bayamon district of Puerto Rico, FDA and GSK say in a Feb. 24 release. Stolen consumer products include full cases of Tums antacid, Sensodyne toothpaste, Poligrip denture adhesive and Ecotrin aspirin. This is not the first time GSK was victimized. Thieves also stole a tractor trailer filled with OTC products from the firm last November and before that they stole two lots of Advair Diskus from a distribution facility last August. GSK and FDA are looking for the stolen products, and the manufacturer warns consumers not to use products with tampered or damaged packaging
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.